nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloropyramine—PTK2—endothelium—acquired immunodeficiency syndrome	0.122	0.175	CbGeAlD
Chloropyramine—PTK2—blood plasma—acquired immunodeficiency syndrome	0.109	0.155	CbGeAlD
Chloropyramine—PTK2—skin of body—acquired immunodeficiency syndrome	0.0522	0.0747	CbGeAlD
Chloropyramine—PTK2—lymphoid tissue—acquired immunodeficiency syndrome	0.0423	0.0605	CbGeAlD
Chloropyramine—PTK2—digestive system—acquired immunodeficiency syndrome	0.0417	0.0597	CbGeAlD
Chloropyramine—PTK2—blood—acquired immunodeficiency syndrome	0.0398	0.0569	CbGeAlD
Chloropyramine—PTK2—spinal cord—acquired immunodeficiency syndrome	0.0383	0.0548	CbGeAlD
Chloropyramine—PTK2—vagina—acquired immunodeficiency syndrome	0.0369	0.0527	CbGeAlD
Chloropyramine—PTK2—lung—acquired immunodeficiency syndrome	0.0349	0.0499	CbGeAlD
Chloropyramine—PTK2—nervous system—acquired immunodeficiency syndrome	0.0323	0.0462	CbGeAlD
Chloropyramine—PTK2—central nervous system—acquired immunodeficiency syndrome	0.0311	0.0445	CbGeAlD
Chloropyramine—PTK2—brain—acquired immunodeficiency syndrome	0.0247	0.0353	CbGeAlD
Chloropyramine—PTK2—EPHB-mediated forward signaling—ACTG1—acquired immunodeficiency syndrome	0.024	0.0807	CbGpPWpGaD
Chloropyramine—PTK2—lymph node—acquired immunodeficiency syndrome	0.0238	0.0341	CbGeAlD
Chloropyramine—PTK2—Regulation of actin dynamics for phagocytic cup formation—ACTG1—acquired immunodeficiency syndrome	0.0184	0.062	CbGpPWpGaD
Chloropyramine—PTK2—Syndecan-4-mediated signaling events—CXCL12—acquired immunodeficiency syndrome	0.0177	0.0596	CbGpPWpGaD
Chloropyramine—PTK2—Syndecan-4-mediated signaling events—CXCR4—acquired immunodeficiency syndrome	0.0177	0.0596	CbGpPWpGaD
Chloropyramine—PTK2—Fcgamma receptor (FCGR) dependent phagocytosis—ACTG1—acquired immunodeficiency syndrome	0.0139	0.0468	CbGpPWpGaD
Chloropyramine—PTK2—Syndecan-4-mediated signaling events—CCL5—acquired immunodeficiency syndrome	0.0135	0.0453	CbGpPWpGaD
Chloropyramine—HRH1—digestive system—acquired immunodeficiency syndrome	0.013	0.0186	CbGeAlD
Chloropyramine—PTK2—EPH-Ephrin signaling—ACTG1—acquired immunodeficiency syndrome	0.0124	0.0415	CbGpPWpGaD
Chloropyramine—HRH1—vagina—acquired immunodeficiency syndrome	0.0115	0.0165	CbGeAlD
Chloropyramine—HRH1—lung—acquired immunodeficiency syndrome	0.0109	0.0156	CbGeAlD
Chloropyramine—HRH1—nervous system—acquired immunodeficiency syndrome	0.0101	0.0144	CbGeAlD
Chloropyramine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.0097	0.0139	CbGeAlD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.00855	0.0287	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—CXCR4—acquired immunodeficiency syndrome	0.00819	0.0275	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—CXCL12—acquired immunodeficiency syndrome	0.00819	0.0275	CbGpPWpGaD
Chloropyramine—PTK2—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	0.00776	0.0261	CbGpPWpGaD
Chloropyramine—HRH1—brain—acquired immunodeficiency syndrome	0.0077	0.011	CbGeAlD
Chloropyramine—HRH1—lymph node—acquired immunodeficiency syndrome	0.00744	0.0106	CbGeAlD
Chloropyramine—PTK2—Focal Adhesion—ACTG1—acquired immunodeficiency syndrome	0.00704	0.0237	CbGpPWpGaD
Chloropyramine—PTK2—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	0.00626	0.0211	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.00459	0.0154	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.0045	0.0151	CbGpPWpGaD
Chloropyramine—HRH1—IL-4 Signaling Pathway—IL4—acquired immunodeficiency syndrome	0.00431	0.0145	CbGpPWpGaD
Chloropyramine—PTK2—Angiopoietin receptor Tie2-mediated signaling—TNF—acquired immunodeficiency syndrome	0.00358	0.012	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.00353	0.0119	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00343	0.0115	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—acquired immunodeficiency syndrome	0.00341	0.0115	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.00328	0.011	CbGpPWpGaD
Chloropyramine—PTK2—Caspase Cascade in Apoptosis—TNF—acquired immunodeficiency syndrome	0.00322	0.0108	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—IL2—acquired immunodeficiency syndrome	0.00302	0.0101	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.00289	0.00973	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.00283	0.00952	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00273	0.00916	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00247	0.00829	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.00238	0.008	CbGpPWpGaD
Chloropyramine—PTK2—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	0.00226	0.00759	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00208	0.00698	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00207	0.00697	CbGpPWpGaD
Chloropyramine—Rosiglitazone—ALB—acquired immunodeficiency syndrome	0.00207	0.597	CrCbGaD
Chloropyramine—HRH1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00188	0.00631	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.00186	0.00627	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.00186	0.00627	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.00184	0.0062	CbGpPWpGaD
Chloropyramine—HRH1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00178	0.00598	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00176	0.00591	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—ACTG1—acquired immunodeficiency syndrome	0.00169	0.00567	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00168	0.00566	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.00168	0.00564	CbGpPWpGaD
Chloropyramine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00167	0.00562	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—IL6—acquired immunodeficiency syndrome	0.00157	0.00528	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00152	0.00512	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.0015	0.00503	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—IL6—acquired immunodeficiency syndrome	0.00148	0.00499	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.00146	0.00491	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—TNF—acquired immunodeficiency syndrome	0.00145	0.00487	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00143	0.00481	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00143	0.00481	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—MBL2—acquired immunodeficiency syndrome	0.00138	0.00466	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00128	0.00431	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.00126	0.00425	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00126	0.00423	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00126	0.00423	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00116	0.0039	CbGpPWpGaD
Chloropyramine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00115	0.00385	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00114	0.00382	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00109	0.00367	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00109	0.00367	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00109	0.00366	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CCR2—acquired immunodeficiency syndrome	0.00109	0.00365	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00107	0.00358	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00104	0.00349	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000981	0.0033	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000978	0.00329	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000963	0.00324	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000951	0.0032	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CD79A—acquired immunodeficiency syndrome	0.000949	0.00319	CbGpPWpGaD
Chloropyramine—Clomipramine—ALB—acquired immunodeficiency syndrome	0.00083	0.239	CrCbGaD
Chloropyramine—HRH1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00083	0.00279	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000776	0.00261	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000774	0.0026	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000771	0.00259	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CD8A—acquired immunodeficiency syndrome	0.000765	0.00257	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CSF2—acquired immunodeficiency syndrome	0.000765	0.00257	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000755	0.00254	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000747	0.00251	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000736	0.00247	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000702	0.00236	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00066	0.00222	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00066	0.00222	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000658	0.00221	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000655	0.0022	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—IL6—acquired immunodeficiency syndrome	0.000647	0.00218	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000629	0.00212	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000629	0.00212	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000616	0.00207	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000616	0.00207	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000595	0.002	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—TNF—acquired immunodeficiency syndrome	0.000573	0.00193	CbGpPWpGaD
Chloropyramine—Chlorpromazine—ALB—acquired immunodeficiency syndrome	0.000569	0.164	CrCbGaD
Chloropyramine—HRH1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000569	0.00191	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00056	0.00188	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00056	0.00188	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000502	0.00169	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000495	0.00166	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000469	0.00158	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—IL6—acquired immunodeficiency syndrome	0.000462	0.00155	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000462	0.00155	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—IFNG—acquired immunodeficiency syndrome	0.000455	0.00153	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000452	0.00152	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00045	0.00151	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CD4—acquired immunodeficiency syndrome	0.000439	0.00148	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000426	0.00143	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000422	0.00142	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000419	0.00141	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—IL6—acquired immunodeficiency syndrome	0.000408	0.00137	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—IL2—acquired immunodeficiency syndrome	0.000404	0.00136	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000389	0.00131	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000384	0.00129	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000352	0.00118	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000331	0.00111	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000331	0.00111	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000261	0.000879	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000251	0.000846	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000248	0.000833	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000244	0.00082	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—IL6—acquired immunodeficiency syndrome	0.000238	0.000799	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000227	0.000762	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000222	0.000745	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000154	0.000517	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000131	0.00044	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.00013	0.000438	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.69e-05	0.000259	CbGpPWpGaD
